Skip to main content
. 2019 Mar 21;10:274. doi: 10.3389/fneur.2019.00274

Table 1.

Derivation study characteristics.

Scale Derivation dataset Location Recruitment type Enrolment dates Stroke type Exclusion criteria of note
ASTRAL Acute Stroke Registry and Analysis of Lausanne Switzerland Single-center Jan 2003 to Jul 2010 Ischemic Pre-stroke mRS > 2
DRAGON Bespoke cohort Finland Single-center 1995 to Sep 2010 Ischemic Basilar artery occlusions
FSV Stroke Outcome Study Canada Single-center 2001 to 2002 Ischemic, hemorrhagic
iSCORE Registry of the Canadian Stroke Network Canada Multi-center Jul 2003 to Jun 2008 Ischemic
PLAN Registry of the Canadian Stroke Network Canada Multi-center Jul 2003 to Mar 2008 Ischemic Patients receiving IV-tPA
SNARL Endovascular registry Unclear Multi-center Sep 2009 to Jul 2011 Ischemic
SOAR Anglia Stroke and Heart Clinical Network Database United Kingdom Multi-center 1997 to 2010 Ischemic, hemorrhagic
SPI Carotid ultrasound register United States Single-center Jan 1984 to Feb 1987 Ischemic Artificial heart valves, previous cerebrovascular event
S-TPI NINDS 1 & 2, ATLANTIS A & B, ECASS 2 cohorts International Multi-center Jan 1991 to Jul 1998* Ischemic Multiple, related to primary randomized control trials; minor strokes
THRIVE MERCI, Multi MERCI cohorts International Multi-center May 2001 to Dec 2003; Jan 2004 to Jul 2006 Ischemic Multiple, related to primary single-arm trials.

IV-tPA, intravenous tissue plasminogen activator; mRS, modified Rankin Scale.

*

Combined recruitment period for all trials.